The stock of Cumberland Pharmaceuticals will enter Thursday trading with energy after a robust Wednesday that saw the shares gain nearly 18 percent in value.

The surge followed a sluggish Tuesday for the stock after the biopharmaceutical company reported its third-quarter financials.